InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Daverman Benjamin James. Officer active across 1 company, notably Maravai Lifesciences Holdings, INC.. Aggregated, 4 filings have been logged. Activity tracked since 19 November 2021. The latest transaction was filed on 16 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Daverman Benjamin James
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
89,139 股@ US$2.1644.7% 占其流量Class A Common StockSEC:0001823239-25-000089:0
20,645 股@ US$10.78100.0% 占其流量Class A Common StockSEC:0001823239-24-000076:0
24,000 股0Class A Common StockSEC:0001823239-23-000056:0
4,271 股0Class A Common StockSEC:0000899243-21-045772:0
4 条申报中的 4 条
About Daverman Benjamin James
DAVERMAN BENJAMIN JAMES is a declarant linked to Maravai Lifesciences Holdings, INC., where the listed company role is Director. He has 4 filings in total, and in the sampled recent filings the modal transaction nature is Attribution, with amounts of EUR 205825.9937570995 on 2024-05-24 and EUR 166682.0878603167 on 2025-06-18.
